Key result
Ultrasound-triggered xenon liposomes reduce rat infarct volume by ~75%.
Why the study?
Xenon has potential as an effective and nontoxic neuroprotectant, but delivery methods are limited and need improvement.
Answers are grounded in this paper and cite their sources.
Ultrasound-triggered local release of xenon from echogenic liposomes represents a novel noninvasive strategy that significantly reduces infarct volume and improves behavioral outcomes in a rat model of cerebral ischemia.
Background— Ischemia-related neurological injury is a primary cause of stroke disability. Studies have demonstrated that xenon (Xe) may have potential as an effective and nontoxic neuroprotectant. Xe delivery is, however, hampered by lack of suitable administration methods. We have developed a pressurization-freeze method to encapsulate Xe into echogenic liposomes (Xe-ELIP) and have modulated local gas release with transvascular ultrasound exposure. Methods and Results— Fifteen microliters of Xe were encapsulated into each 1 mg of liposomes (70% Xe and 30% argon). Xe delivery from Xe-ELIP into cells and consequent neuroprotective effects were evaluated with oxygen/glucose-deprived and control neuronal cells in vitro. Xe-ELIP were administered into Sprague-Dawley rats intravenously or intra-arterially after right middle cerebral artery occlusion. One-megahertz low-amplitude (0.18 MPa) continuous wave ultrasound directed onto the internal carotid artery triggered Xe release from circulating Xe-ELIP. Effects of Xe delivery on ischemia-induced neurological injury and disability were evaluated. Xe-ELIP delivery to oxygen/glucose-deprived neuronal cells improved cell viability in vitro and resulted in a 48% infarct volume decrease in vivo. Intravenous Xe-ELIP administration in combination with the ultrasound directed onto the carotid artery enhanced local Xe release from circulating Xe-ELIP and demonstrated 75% infarct volume reduction. This was comparable to the effect after intra-arterial administration. Behavioral tests on limb placement and grid and beam walking correlated with infarct reduction. Conclusions— This novel methodology may provide a noninvasive strategy for ultrasound-enhanced local therapeutic gas delivery for cerebral ischemia–related injury while minimizing systemic side effects.
No takes yet. Share an insight, caveat, or question.
Britton et al. (2010) studied Ischemia-related neurological injury. Xenon encapsulated into echogenic liposomes (Xe-ELIP) with transvascular ultrasound vs. Control/no intervention was evaluated on Infarct volume reduction. Intravenous administration of xenon-encapsulated echogenic liposomes combined with targeted carotid ultrasound enhanced local xenon release and demonstrated a 75% infarct volume reduction in rats.
Synapse has enriched 10 related papers. Consider them for comparative context: